Evidence map›Paper›PMID 27155614›Full record

ArticleInvestigational new drugs2016

Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells.

Ariane Chan, A Jonathan Singh, Peter T Northcote, John H Miller

Abstract read
PubMed Publisher
In one paragraph

Article in Investigational new drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ariane ChanSchool of Biological Sciences, Victoria University of Wellington, PO Box 600, Wellington, 6140, New Zealand.
A Jonathan SinghCentre for Biodiscovery, Victoria University of Wellington, PO Box 600, Wellington, 6140, New Zealand.
Peter T NorthcoteCentre for Biodiscovery, Victoria University of Wellington, PO Box 600, Wellington, 6140, New Zealand.
John H MillerSchool of Biological Sciences, Victoria University of Wellington, PO Box 600, Wellington, 6140, New Zealand. john.h.miller@vuw.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To ensure proper chromosome segregation, mitosis is tightly regulated by the spindle assembly checkpoint (SAC). Low concentrations of microtubule-stabilizing agents can induce aneuploid populations of cells in the absence of G2/M block, suggesting pertubation of the spindle checkpoint. We investigated the effects of peloruside A, a microtubule-stabilizing agent, on expression levels of several key cell cycle proteins, MAD2, BUBR1, p55CDC and cyclin B1. Synchronized 1A9 ovarian carcinoma cells were allowed to progress through the cell cycle in the presence or absence of peloruside A. Co-immunoprecipitation and Western blotting were used to probe the cell cycle kinetics of MAD2 and BUBR1 dissociation from p55CDC. Using confocal microscopy, we investigated whether premature dissociation of MAD2 and BUBR1 at low (40 nM) but not high (100 nM) concentrations of peloruside A was caused by defects in the attachment of chromosomes to the mitotic spindle. An increased frequency of polar chromosomes was observed at low concentrations of peloruside A, suggesting that an increased frequency of pseudo-metaphase cells, which are not detected by the spindle assembly checkpoint, may be underlying the induction of aneuploidy.

Indexed as

AneuploidyAntineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicCell Cycle ProteinsCell Line, TumorFemaleHumansLactonesMicrotubulesMitosisOvarian NeoplasmsAntineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicCell Cycle ProteinsLactonespeloruside AAneuploidyBUBR1MAD2MicrotubuleMitosisp55CDCPeloruside ASpindle checkpoint

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.